GlassScriptPhysician profile
Kelly Thalacker
NPI 1184263451
$4,591.90
in general payments reported to CMS, 2019-2025
18 companies · $1,357 in 2025
The $1,357 reported for 2025 was more than what 89% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $945 · 2022: $780 · 2023: $716 · 2024: $794 · 2025: $1,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,867.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $671.96 | 2021-2024 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $558.26 | 2021-2023 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $555.94 | 2021-2025 | Entyvio, Gattex |
| Abbvie INC. | $545.10 | 2021-2025 | |
| Madrigal Pharmaceuticals | $415.57 | 2025 | Rezdiffra |
| Evoke Pharma, INC. | $351.18 | 2021-2024 | Gimoti |
| Ardelyx, INC. | $258.67 | 2023-2025 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $249.74 | 2022-2024 | Dupixent |
| Intercept Pharmaceuticals, INC. | $200.48 | 2024-2025 | |
| Gilead Sciences, INC. | $125.00 | 2025 | Livdelzi |
| Astrazeneca Pharmaceuticals LP | $124.80 | 2021 | |
| Novo Nordisk INC | $124.74 | 2025 | Wegovy |
| Ipsen Biopharmaceuticals, INC | $105.34 | 2025 | Iqirvo |
| Endogastric Solutions, INC | $96.18 | 2024 | Esophyx |
| Mallinckrodt Hospital Products INC. | $94.70 | 2023 | Terlivaz |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $80.79 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.78 | 2025 | Jardiance |
| Amgen INC. | $15.67 | 2024 | Enbrel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Thalacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.